Clinical Trials Browser

Recruiting × 1-dodecylpyridoxal × Gynecologic × Clear all

NCT06161025 2026-01-12

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06687070 2025-02-26

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Phase 1 Recruiting

GynecologicOther solid neoplasm

Platinum-resistant Recurrent Ovarian Cancer